About NeuroPoint Dx
NeuroPoint Dx is a company based in Madison (United States) founded in 2006. NeuroPoint Dx offers products and services including NPDX ASD Blood Test and Research Publications. NeuroPoint Dx operates in a competitive market with competitors including Lineagen, Linus Biotechnology, MARAbio, Pediatric Bioscience and SensOmics, among others.
Products & Services of NeuroPoint Dx
NeuroPoint Dx offers a comprehensive portfolio of products and services, including NPDX ASD Blood Test and Research Publications.
Blood test for early autism detection and metabolic subtype analysis.
Scientific papers on autism metabolism and treatment insights.
Apps and channels of NeuroPoint Dx
its YouTube channel NeuroPointDX has 7 subscribers and 1 videos.
Videos from NeuroPoint Dx
The most watched videos on NeuroPoint Dx's YouTube channel, NeuroPointDX (7 subscribers). Click a video to play it here.
More on NeuroPointDX.
People of NeuroPoint Dx
14 people are tracked at NeuroPoint Dx (1 in leadership, 13 in board & advisors).
| Name | Role | Group |
|---|---|---|
Elizabeth Donley | CEO | Leadership |
G. Sitta Sittampalam | Scientific Advisor | Board & advisors |
Anthony P. Shuber | Director | Board & advisors |
Don M. Hardison | Director | Board & advisors |
Robert E. Burrier | Scientific Advisor | Board & advisors |
Minesh Mehta | Scientific Advisor | Board & advisors |
Barbara L. Handelin | Director | Board & advisors |
Marc Schneebaum | Director | Board & advisors |
Steven Fischer | Scientific Advisor | Board & advisors |
David G. Amaral | Scientific Advisor | Board & advisors |
Denise M. Ney | Scientific Advisor | Board & advisors |
Andrew Morgan | Director | Board & advisors |
Marvin Natowicz | Scientific Advisor | Board & advisors |
Oliver Fiehn | Scientific Advisor | Board & advisors |
Complete people profiles for NeuroPoint Dx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of NeuroPoint Dx
NeuroPoint Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lineagen, Linus Biotechnology, MARAbio, Pediatric Bioscience and SensOmics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lineagen.com | 2002 | Salt Lake, United States | $66.93M | 40 | Sequencing-based diagnostic tests and services for autism are provided. | |
| linusbio.com | 2020 | New York, United States | $47.65M | – | Developer of diagnostic tests for central nervous system and gastrointestinal disorders | |
| marabio.com | 2016 | Salt Lake, United States | $19.06M | – | A blood test for maternal autoantibody-related autism is developed. | |
| pediatricbioscience.com | 2006 | Sacramento, United States | $2.44M | – | Provides blood biomarker-based diagnostics for autism spectrum disorders. | |
| sensomics.com | 2007 | Toronto, Canada | – | – | Precision medicine for children's health is provided through genomic integration. | |
| fbbbio.com | 2020 | Coralville, United States | $401,000 | – | In-vitro diagnostic tests for COVID-19 and neurological diseases are developed. | |
| autism-biotech.com | 2011 | Belfast, United Kingdom | $51,300 | – | Develops biochemical tests for early autism diagnosis. | |
| metabolus.com | 2015 | San Diego, United States | – | 33 | Develops diagnostics for neurodegenerative and neuropsychiatric disorders. | |
| neuraclegen.com | 2018 | Seoul, South Korea | – | – | Develops gene therapies using adeno-associated virus technology to treat various diseases. |
Detailed competitors of NeuroPoint Dx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuropoint Dx
Complete news archive for NeuroPoint Dx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to NeuroPoint Dx
10 companies that operate in the same segment as NeuroPoint Dx (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NeuroPoint Dx
NeuroPoint Dx was founded in 2006.
NeuroPoint Dx is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
NeuroPoint Dx develops diagnostic tests using metabolomics for neuro-developmental disorders. It uses the metabolomics platform, as developed by parent company Stemina Biomarker Discovery, to diagnose and prescribe best treatments for neurological disorders. First application is autism-spectrum disorders.
NeuroPoint Dx's top competitors include Linus Biotechnology, MARAbio and Lineagen.
NeuroPoint Dx offers NPDX ASD Blood Test and Research Publications.